Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Post-cesarean analgesia: continuous wound infusion of ropivacaine + diclofenac versus intrathecal morphine
2008-004643-11Phase 3Terminated
- Sponsor
- CHU Nîmes
- Start
- Mar 2009
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of ropivacaine, diclofenac and morphine in postoperative pain (2 arms), sponsored by CHU Nîmes. Primary endpoint: Pain visual analog scale at 36 hours in sitting position. Started Mar 2009; status: terminated.
02
Drugs
ropivacainediclofenacmorphine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on 2008-004643-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-004643-11.